CB1 receptor-G protein association: Subtype selectivity is determined by distinct intracellular domains

European Journal of Biochemistry

Volumn 268, Issue 3, 2001, Pages 499-505

  Mukhopadhyay, Somnath ^a   Howlett, Allyn C ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

Adenylate cyclase; Cannabinoid receptors; G protein coupled receptors; N18TG2 neuroblastoma

Indexed keywords

ADENYLATE CYCLASE; CANNABINOID 1 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); PEPTIDE; PERTUSSIS TOXIN; PROTEIN SUBUNIT; ADENYLATE CYCLASE TOXIN; BORDETELLA VIRULENCE FACTOR; CANNABINOID RECEPTOR; DRUG RECEPTOR; GUANOSINE TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME INHIBITION; IMMUNOPRECIPITATION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; ANIMAL; CELL CULTURE; CHEMISTRY; CHO CELL; DOSE RESPONSE; DRUG ANTAGONISM; HAMSTER; HUMAN; METABOLISM; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SERODIAGNOSIS; WESTERN BLOTTING;

ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; ANIMALS; BLOTTING, WESTERN; CELL MEMBRANE; CHO CELLS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; GTP-BINDING PROTEINS; GUANOSINE TRIPHOSPHATE; HUMANS; PEPTIDES; PERTUSSIS TOXIN; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TUMOR CELLS, CULTURED; VIRULENCE FACTORS, BORDETELLA;

EID: 0034741597     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2001.01810.x     Document Type: Article

References (32)

1. Rethinking receptor-G protein-effector interactions
2. Diversity and selectivity of receptor-G protein interaction
3. The many faces of G protein signaling
4. Diversity of G proteins in signal transduction
5. Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor
6. Antagonism of catecholamine receptor signaling by expression of cytoplasmic domains of the receptors
7. Chimeric muscarinic cholinergic: β-adrenergic receptors that are functionally promiscuous among G proteins
8. Pharmacology of cannabinoid receptors
9. Cannabimimetic fatty acid derivatives: The anandamide family and other 'endocannabinoids'
10. Pharmacology of cannabinoid receptor ligands
11. 1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies
12. 1 cannabinoid receptor C-terminal juxtamembrane region: Structural requirements determined by peptide analysis
13. 1 cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain
14. Identification of the pertussis toxin-sensitive G proteins in platelets, megakaryocytes, and human erythroleukemia cells
15. 1 cannabinoid receptor: Cellular regulation and distribution in N18TG2 neuroblastoma cells
16. Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes
17. Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins
18. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1
19. Effect of forskolin and isobutylmethylxanthine on delta-opioid receptor activity in neuroblastoma x glioma NG108-15 cells
20. o in neuroblastoma x glioma hybrid cells in response to dibutyryl cyclic AMP
21. 1 cannabinoid receptor
22. 1 receptor ligands
23. sα
24. 2 dopamine receptor in a reconstituted system
25. o
26. Specificity of receptor-G protein interactions: Searching for the structure behind the signal
27. Molecular basis of receptor/G protein-coupling selectivity
28. Identification of G-protein binding sites of the human interleukin-8 receptors by functional mapping of the intracellular loops
29. Identification of the critical domains of the δ-opioid receptor involved in G protein coupling using site-specific synthetic peptides
30. 2-adrenergic receptors based upon characteristics in primary structure
31. Mapping of G protein coupling sites of the angiotensin II type 1 receptor
32. Multisite contacts involved in coupling of the β-adrenergic receptor with the stimulatory guanine-nucleotide-binding regulatory protein. Structural and functional studies by β-receptor-site-specific synthetic peptides